期刊文献+

前列地尔注射液辅助治疗急性心肌梗死后急性肾损伤37例 被引量:6

下载PDF
导出
摘要 目的观察前列地尔注射液治疗急性心肌梗死后急性肾损伤的临床疗效。方法连续筛选急性心肌梗死后发生急性肾损伤的患者共72例,随机分为治疗组37例和对照组35例。两组均给予常规治疗,治疗组加用前列地尔注射液10μg+氯化钠注射液100 mL静脉滴注,qd,连用7 d。对两组患者肾功能指标进行分析。治疗组患者使用前列地尔注射液期间观察药物不良反应。结果治疗组血清肌酐、尿素氮、胱抑素C均显著低于对照组(均P<0.01),肾小球滤过率、尿量均显著高于对照组(均P<0.01)。治疗组患者使用前列地尔注射液期间无严重不良反应发生。结论常规治疗基础上使用前列地尔注射液对急性心肌梗死后急性肾损伤患者肾功能恢复有一定促进作用。
出处 《医药导报》 CAS 北大核心 2013年第4期476-477,共2页 Herald of Medicine
  • 相关文献

参考文献8

  • 1PARIKH C R,COCA S G,WANG Y,et al.Longterm prognosis of acute kidney injury after acute myocardial infarction [J].Arch Intem Med,2008,168(9):987-995.
  • 2RONCO C,LEVIN A,WARNOCK D G,et al.Improving outcomes from acute kidney injury(AKI):Report on an initiative [J].Int J Artif Organs,2007,30(5):373-376.
  • 3RONCO C,MCCULLOUGH P,ANKER S D,et al.Cardiorenal syndromes:report from the consensus conference of the acute dialysis quality initiative [J].Eur Heart J,2010,31(6):703-711.
  • 4IWANAGA Y,MIYAZAKI S.Heart failure,chronic kidney disease,and biomarkersan integrated viewpoint[J].Circ J,2010,74(7):1274-1282.
  • 5MAISEL A S,KATZ N,HILLEGE H L,et al.Biomarkers in kidney and heart disease[J].Nephrol Dial Transplant,2011,26(1):62-74.
  • 6NAKAYAMA Y,NONOGUCHI H,KIYAMA S,et al.Longterm renoprotective effect of combination therapy with prostaglandin E1 and angiotensinconverting enzyme inhibitor in patients with chronic renal failure[J].Hypertens Res,2005,28(9):733-739.
  • 7TAKAHASHI H K,XUE D,IWAGAKI H,et al.Prostaglandin E1initiated immune regulation during human mixed lymphocyte reaction[J].Clin Immunol,2005,115(1):85-92.
  • 8黄回英,李慧,杨柳,朱桃英.中药灌肠联合前列地尔治疗慢性肾衰竭40例效果探讨[J].护理学杂志(综合版),2005,20(3):41-42. 被引量:4

二级参考文献7

共引文献3

同被引文献60

  • 1沈建明,邓妍妍,张艳霞,夏敬明,张迎春.不同剂量乌司他丁对庆大霉素急性肾损伤的影响[J].湖北医药学院学报,2013,32(4):299-301. 被引量:3
  • 2REWA O, BAGSHAW S M. Acute kidney injury-epidemio- logy, outcomes and economics [ J ]. Nat Rev Nephrol, 2014, 10(4) : 193-207.
  • 3PERAZELLA M A.Drug use and nephrotoxicity in the inten- sive care unit[ J] .Kidney Int, 2012,81 (12) : 1172-1178.
  • 4JESMIN S, SHIMOJO N, YAMAGUCHI N, et al. Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat model[ ] ] .Life Sei, 2014,102(2) : 127-133.
  • 5PAPACHRISTOU E, PAPADIMITROPOULOS A, KOTSA- NTIS P, et al. Interaction of endothelin-1 and nitric oxide pathways in human tubular epithelial cells under the influence of cyclosporine-A [ J ]. Ren Fail, 2010, 32 ( 6 ) : 727-732.
  • 6SINGH A P ,JUNEMANN A, MUTHURAMAN A,et al.Ani- mal models of acute renal failure [ J l.Pharmacol Rep, 2012, 64(1) :31-44.
  • 7ZHANG J, BROWN R P, SHAW M, et al. Immunoloc- alization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats : relationship to renal distributions of iNOS and nitrotyrosine [ J] .Toxicol Patho1,2008 ,36( 3) :397-409.
  • 8QUIROS Y, VICENTE-VICENTE L, MORALES A I, et al. An integrative overview on the mechanisms underXying the renal tubular cytotoxicity of gentamicin [ J ]. Toxicol Sci, 2011,119(2) :245-256.
  • 9VALDIVIELSO J M, RIVAS-CABANERO L, MORALES A I, et al. Increased renal glomerular endothelin-1 release in gentamicin-induced nephrotoxicity [ J ]. Int J Exp Pathol, 1999,80 ( 5 ) : 265- 270.
  • 10PESSOA E A, CONVENTO M B, SILVA R G, et al. Gent- amicin-induced preconditioning of proximal tubular LLC- PK1 cells stimulates nitric oxide production but not the synthesis of heat shock protein [ J ]. Braz J Med Biol Res, 2009,42(7) :614-620.

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部